Literature DB >> 29747734

Hypertensive Disorders in Pregnancy.

Amelia L M Sutton1, Lorie M Harper2, Alan T N Tita2.   

Abstract

Hypertensive disorders of pregnancy are a heterogeneous group of conditions that include chronic hypertension, gestational hypertension, preeclampsia, and preeclampsia superimposed on chronic hypertension. These disorders account for a significant proportion of perinatal morbidity and mortality nearly 10% of all maternal deaths in the United States. Given the substantial health burden of hypertensive disorders in pregnancy, there is increasing interest in optimizing management of these conditions. This article summarizes the diagnosis and management of each of the disorders in the spectrum of hypertension in pregnancy and highlights recent updates in the field.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chronic hypertension; Eclampsia; Gestational hypertension; Preeclampsia

Mesh:

Year:  2018        PMID: 29747734     DOI: 10.1016/j.ogc.2018.01.012

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  26 in total

1.  Portfolio analysis on preeclampsia and pregnancy-associated hypertension research funded by the National Heart, Lung, and Blood Institute.

Authors:  Christine Maric-Bilkan
Journal:  Physiol Genomics       Date:  2018-09-28       Impact factor: 3.107

2.  Efficacy of aspirin combined with labetalol on gestational hypertension and effect on serum PAPP-A, APN and HMGB1.

Authors:  Feiyue Zhang; Bide Duan; Yanming Liu; Cuicui Wang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Small extracellular vesicles from plasma of women with preeclampsia increase myogenic tone and decrease endothelium-dependent relaxation of mouse mesenteric arteries.

Authors:  Juliana S Powell; Robin E Gandley; Emily Lackner; Andrea Dolinish; Yingshi Ouyang; Robert W Powers; Adrian E Morelli; Carl A Hubel; Yoel Sadovsky
Journal:  Pregnancy Hypertens       Date:  2022-02-19       Impact factor: 2.494

4.  Long non-coding RNA myocardial infarction associated transcript expression and clinical significance in patients with hypertension during pregnancy.

Authors:  Xiaoli Wu; Ruifen Su
Journal:  Ir J Med Sci       Date:  2021-10-15       Impact factor: 2.089

Review 5.  Prevention, Diagnosis, and Management of Hypertensive Disorders of Pregnancy: a Comparison of International Guidelines.

Authors:  Rachel G Sinkey; Ashley N Battarbee; Natalie A Bello; Christopher W Ives; Suzanne Oparil; Alan T N Tita
Journal:  Curr Hypertens Rep       Date:  2020-08-27       Impact factor: 5.369

Review 6.  Research Recommendations From the National Institutes of Health Workshop on Predicting, Preventing, and Treating Preeclampsia.

Authors:  Christine Maric-Bilkan; Vikki M Abrahams; S Sonia Arteaga; Ghada Bourjeily; Kirk P Conrad; Janet M Catov; Maged M Costantine; Brian Cox; Vesna Garovic; Eric M George; Alison D Gernand; Arun Jeyabalan; S Ananth Karumanchi; Aaron D Laposky; Menachem Miodovnik; Megan Mitchell; Victoria L Pemberton; Uma M Reddy; Mark K Santillan; Eleni Tsigas; Kent L R Thornburg; Kenneth Ward; Leslie Myatt; James M Roberts
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

Review 7.  Intergenerational Effects of Health Issues Among Women of Childbearing Age: a Review of the Recent Literature.

Authors:  Lydi-Anne Vézina-Im; Theresa A Nicklas; Tom Baranowski
Journal:  Curr Nutr Rep       Date:  2018-12

Review 8.  Out of Office Blood Pressure Measurement in Pregnancy and the Postpartum Period.

Authors:  Natalie A Bello; Eliza Miller; Kirsten Cleary; Ronald Wapner; Daichi Shimbo; Alan T Tita
Journal:  Curr Hypertens Rep       Date:  2018-10-25       Impact factor: 5.369

9.  Genotypic analysis of the female BPH/5 mouse, a model of superimposed preeclampsia.

Authors:  Jenny L Sones; Christina C Yarborough; Valerie O'Besso; Alexander Lemenze; Nataki C Douglas
Journal:  PLoS One       Date:  2021-07-16       Impact factor: 3.240

10.  High Levels of Tumor Necrosis Factor-Alpha Reduce Placental Aquaporin 3 Expression and Impair in vitro Trophoblastic Cell Migration.

Authors:  Rinaldo Rodrigues Dos Passos Junior; Raiany Alves de Freitas; Julieta Reppetti; Yollyseth Medina; Vanessa Dela Justina; Camila Werle Bach; Gisele Facholi Bomfim; Victor Vitorino Lima; Alicia E Damiano; Fernanda R Giachini
Journal:  Front Physiol       Date:  2021-06-29       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.